Results 11 to 20 of about 6,736 (217)

Antibody-Based Strategies to Prevent and Treat Influenza [PDF]

open access: yesFrontiers in Immunology, 2015
Passive immunization using antibodies has been suggested to offer several benefits in comparison to other antiviral treatment options. The potential for seasonal protection arising from a single injection of antibodies is appealing and has been pursued ...
Ram eSasisekharan, Zachary eShriver
doaj   +3 more sources

Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus [PDF]

open access: yesmSphere, 2017
Sialic acids (Sias) are important glycans displayed on the cells and tissues of many different animals and are frequent targets for binding and modification by pathogens, including influenza viruses.
Brian R. Wasik   +9 more
doaj   +5 more sources

Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus [PDF]

open access: yesFrontiers in Immunology
Orf virus (ORFV) is a large DNA virus that can harbor and efficiently deliver viral antigens in swine. Here we used ORFV as a vector platform to deliver chimeric hemagglutinins (HA) of Influenza A virus of swine (IAV-S). Vaccine development against IAV-S
Gabriela Mansano do Nascimento   +4 more
doaj   +2 more sources

Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin [PDF]

open access: yes, 2014
Influenza viruses continuously undergo antigenic changes with gradual accumulation of mutations in hemagglutinin (HA) that is a major determinant in subtype specificity.
Cho, Ki Joon   +7 more
core   +21 more sources

Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.

open access: yesPLoS Biology, 2023
The viral hemagglutinins of conventional influenza A viruses (IAVs) bind to sialylated glycans on host cell surfaces for attachment and subsequent infection. In contrast, hemagglutinins of bat-derived IAVs target major histocompatibility complex class II
Okikiola M Olajide   +10 more
doaj   +1 more source

High-complexity extracellular barcoding using a viral hemagglutinin [PDF]

open access: yesProceedings of the National Academy of Sciences, 2020
While single-cell sequencing technologies have revealed tissue heterogeneity, resolving mixed cellular libraries into cellular clones is essential for many pooled screens and clonal lineage tracing. Fluorescent proteins are limited in number, while DNA barcodes can only be read after cell lysis.
Gavriel Mullokandov   +7 more
openaire   +3 more sources

cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice

open access: yesMolecular Therapy: Nucleic Acids, 2022
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently prevent infectious diseases and are safe in animal models and humans.
Wandi Zhu   +7 more
doaj   +1 more source

A simple procedure for purification of viral hemagglutinin [PDF]

open access: yesVirology, 1962
Peer Reviewed ; http://deepblue.lib.umich.edu/bitstream/2027.42/32311/1/0000379 ...
Mizutani, H.   +3 more
openaire   +3 more sources

Structural and Functional Aspects of G-Quadruplex Aptamers Which Bind a Broad Range of Influenza A Viruses

open access: yesBiomolecules, 2020
An aptamer is a synthetic oligonucleotide with a unique spatial structure that provides specific binding to a target. To date, several aptamers to hemagglutinin of the influenza A virus have been described, which vary in affinity and strain specificity ...
Anastasia A. Novoseltseva   +9 more
doaj   +1 more source

The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. [PDF]

open access: yesPLoS ONE, 2013
Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent.
Gunnveig Grødeland   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy